期刊文献+

糖尿病药物及胰岛素治疗新进展 被引量:18

Progress in the research into drugs and insulin treatment for diabetes mellitus
原文传递
导出
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2007年第1期29-32,共4页 Chinese Journal of Practical Internal Medicine
关键词 糖尿病 血糖 药物治疗 胰岛素 Diabetes mellitus Blood glucose Drug therapy Insulin
  • 相关文献

参考文献16

  • 1Zander M,Madsbad S,Madsen JL,et al.Effect of 6-week course of glucagon-like peptide 1 on glycaemic control,insulin sensitivity,and b -cell function in type 2 diabetes:a parallelgroup study[J].Lancet,2002,359 (9309):824-830.
  • 2Ahren B,Simonsson E,Larsson H,et al.Inhibition of dipeptidyl peptidase-Ⅳimproves metabolic control over a 4 -week study period in type 2 diabetes[J].Diabetes Care,2002,25(5):869-875.
  • 3Ahren B,Gomis R,Standl E,et al.Twelve-and 52-week efficacy of the dipeptidyl peptidase-Ⅳ inhibitor LAF237 in metformin-treated patients with type 2 diabetes[J].Diabetes Care,2004,27 (12):2874-2880.
  • 4Ahren B,Pacini G,Foley JE,et al.Improved meal-related beta -cell function and insulin sensitivity by the dipeptidyl peptidase-Ⅳ inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year[J].Diabetes Care,2005,28(8):1936-1940.
  • 5Kolterman OG,Buse JB,Fineman MS,et al.Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes[J].J Clin Endocrinol Metab,2003,88 (7):3082-3089.
  • 6Marzban,Lucy,Park,et al.Islet amyloid polypeptide and type 2 diabetes[J].Experim Geronto1,2003,38 (5):347-351.
  • 7Weyer C,Gottlieb A,Kim DD,et al.Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes:a dose-timing study[J].Diabates Care,2003,26 (11):3074-3079.
  • 8Maggs DG,Fineman M,Kornstein J,et al.Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes:a dose-timing study[J].Diabetes Metab Res Rev,2004,20 (1):55 -60.
  • 9Ratner RE,Dickey R,Fineman M,et al.Amylin replacement with pramlintide as an adjunct to insulin therapy improves longterm glycaemic and weight control in Type 1 diabetes mellitus:a 1-year,randomized controlled trial[J].Diabet Med,2004,21 (11):1204-1212.
  • 10Hollander PA,Levy P,Fineman MS,et al.Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes:a 1-year randomized controlled trial[J].Diabates Care,2003,26 (3):784-790.

同被引文献104

引证文献18

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部